Skip to main content
GMED
NYSE Life Sciences

Globus Medical Posts 3Q EPS of $1.04

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$81.52
Mkt Cap
$10.945B
52W Low
$60.255
52W High
$101.398
52W Position info
35% above low
Off High info
20% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

GMED sits 35% above its 52-week low of $60.255 on elevated volume (2.4× avg).

Summary

Globus Medical reported third-quarter EPS of $1.04, with adjusted EPS of $1.23, on sales of $763.7M and net income of $141.2M. That compares with diluted EPS of $1.10 in Q2 2026, when revenue rose 5.9% to $789.6M and operating income more than doubled to $182.4M. The headline gives only the EPS line, so margins and any guidance update are not yet in hand. The print lands two days after the company closed its acquisition of Synaptive Medical, adding cranial neurosurgery robotics, and follows the August deal for Higgs Boson Health. Full quarterly detail will determine whether the Q2 margin improvement held.

At the time of this announcement, GMED was trading at $81.52 on NYSE in the Life Sciences sector, with a market capitalization of approximately $10.9B. The 52-week trading range was $60.26 to $101.40. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

GMED - Latest Insights

GMED
Nov 05, 2026, 5:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $77.60
Real-time Price: $66.89 info
Change: -$10.71 (-14%) info
Market Cap: $8.861B info
GMED
Nov 05, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $80.31
Real-time Price: $66.89 info
Change: -$13.42 (-17%) info
Market Cap: $8.861B info
GMED
Nov 03, 2026, 4:02 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $79.58
Real-time Price: $66.89 info
Change: -$12.69 (-16%) info
Market Cap: $8.861B info
GMED
Aug 26, 2026, 5:57 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $82.96
Real-time Price: $66.89 info
Change: -$16.07 (-19%) info
Market Cap: $8.861B info
GMED
Aug 06, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $84.00
Real-time Price: $66.89 info
Change: -$17.11 (-20%) info
Market Cap: $8.861B info